304 related articles for article (PubMed ID: 22269120)
1. Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease.
Polgar N; Csongei V; Szabo M; Zambo V; Melegh BI; Sumegi K; Nagy G; Tulassay Z; Melegh B
Int J Immunogenet; 2012 Jun; 39(3):247-52. PubMed ID: 22269120
[TBL] [Abstract][Full Text] [Related]
2. Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population.
Ferguson LR; Han DY; Fraser AG; Huebner C; Lam WJ; Morgan AR; Duan H; Karunasinghe N
Mutat Res; 2010 Aug; 690(1-2):108-15. PubMed ID: 20109474
[TBL] [Abstract][Full Text] [Related]
3. Investigation of IL23R, JAK2, and STAT3 gene polymorphisms and gene-gene interactions in Crohn's disease and ulcerative colitis in a Turkish population.
Can G; Tezel A; Gürkan H; Tozkır H; Ünsal G; Soylu AR; Ümit HC
Turk J Gastroenterol; 2016 Nov; 27(6):525-536. PubMed ID: 27852544
[TBL] [Abstract][Full Text] [Related]
4. STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility.
Cénit MC; Alcina A; Márquez A; Mendoza JL; Díaz-Rubio M; de las Heras V; Izquierdo G; Arroyo R; Fernández O; de la Concha EG; Matesanz F; Urcelay E
Genes Immun; 2010 Apr; 11(3):264-8. PubMed ID: 20200543
[TBL] [Abstract][Full Text] [Related]
5. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
6. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
[TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.
Wolfkamp SC; Verstege MI; Vogels EW; Meisner S; Verseijden C; Stokkers PC; te Velde AA
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):965-70. PubMed ID: 22664939
[TBL] [Abstract][Full Text] [Related]
8. The JAK2 variant rs10758669 in Crohn's disease: altering the intestinal barrier as one mechanism of action.
Prager M; Büttner J; Haas V; Baumgart DC; Sturm A; Zeitz M; Büning C
Int J Colorectal Dis; 2012 May; 27(5):565-73. PubMed ID: 22065112
[TBL] [Abstract][Full Text] [Related]
9. JAK2 and STAT3 polymorphisms in a Han Chinese population with Behçet's disease.
Hu K; Hou S; Jiang Z; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):538-41. PubMed ID: 22205606
[TBL] [Abstract][Full Text] [Related]
10. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.
Glas J; Stallhofer J; Ripke S; Wetzke M; Pfennig S; Klein W; Epplen JT; Griga T; Schiemann U; Lacher M; Koletzko S; Folwaczny M; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1737-44. PubMed ID: 19455118
[TBL] [Abstract][Full Text] [Related]
11. rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population.
Glas J; Seiderer J; Pasciuto G; Tillack C; Diegelmann J; Pfennig S; Konrad A; Schmechel S; Wetzke M; Török HP; Stallhofer J; Jürgens M; Griga T; Klein W; Epplen JT; Schiemann U; Mussack T; Lohse P; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Mar; 104(3):665-72. PubMed ID: 19262523
[TBL] [Abstract][Full Text] [Related]
12. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
[TBL] [Abstract][Full Text] [Related]
13. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
[TBL] [Abstract][Full Text] [Related]
14. DLG5 variants in inflammatory bowel disease.
Büning C; Geerdts L; Fiedler T; Gentz E; Pitre G; Reuter W; Luck W; Buhner S; Molnar T; Nagy F; Lonovics J; Dignass A; Landt O; Nickel R; Genschel J; Lochs H; Schmidt HH; Witt H
Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592
[TBL] [Abstract][Full Text] [Related]
15. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
Cantor MJ; Nickerson P; Bernstein CN
Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
[TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate reductase C677T variant in Moroccan patients with inflammatory bowel disease.
Senhaji N; Serbati N; Diakité B; Arazzakou S; Hamzi K; Badre W; Nadifi S
Gene; 2013 May; 521(1):45-9. PubMed ID: 23542077
[TBL] [Abstract][Full Text] [Related]
17. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India.
Mittal RD; Manchanda PK; Bid HK; Ghoshal UC
J Gastroenterol Hepatol; 2007 Jun; 22(6):920-4. PubMed ID: 17565649
[TBL] [Abstract][Full Text] [Related]
18. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
[TBL] [Abstract][Full Text] [Related]
19. Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population.
Chen B; Zeng Z; Hou J; Chen M; Gao X; Hu P
Scand J Gastroenterol; 2009; 44(6):720-6. PubMed ID: 19263269
[TBL] [Abstract][Full Text] [Related]
20. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
Mittal RD; Bid HK; Ghoshal UC
Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
